Original Research
Published on 07 Jun 2022
Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
in Surgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.874749
- 5,094 views
- 5 citations
18 articles related to "Chemotherapy Benefit"
Articles
Original Research
Published on 16 May 2022
Deep Learning-Based Protein Features Predict Overall Survival and Chemotherapy Benefit in Gastric Cancer
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2022.847706
- 3,932 views
- 11 citations
Original Research
Published on 29 Jun 2021
Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit
in Gastrointestinal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2021.692647
- 6,171 views
- 24 citations
Original Research
Published on 18 Nov 2021
Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.745769
- 6,415 views
- 8 citations
Original Research
Published on 14 Aug 2023
Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1223857
- 2,964 views
- 4 citations
Original Research
Published on 19 Feb 2021
Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.636266
- 3,991 views
- 5 citations
Original Research
Published on 19 Sep 2025
Quantitative nodal burden as a predictive marker for chemotherapy benefit in postoperative ampullary adenocarcinoma: a multi-institution population-based study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1610334
- 1,638 views
Original Research
Published on 11 Feb 2021
A Novel Insight Into Fecal Occult Blood Test for the Management of Gastric Cancer: Complication, Survival, and Chemotherapy Benefit After R0 Resection
in Gastrointestinal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2020.526746
- 4,717 views
- 4 citations
Original Research
Published on 09 Nov 2020
Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
in Systems Biology Archive
Frontiers in Genetics
doi 10.3389/fgene.2020.514363
- 4,115 views
- 10 citations
Original Research
Published on 25 Sep 2020
Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2020.557638
- 7,987 views
- 31 citations
Original Research
Published on 30 Oct 2020
Oncotype DX Breast Recurrence Score Distribution and Chemotherapy Benefit Among Women of Different Age Groups With HR-Positive, HER2-Negative, Node-Negative Breast Cancer in the SEER Database
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2020.01583
- 18,304 views
- 17 citations
Original Research
Published on 13 Oct 2022
Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from 18F fluorodeoxyglucose PET/CT images in gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1019386
- 4,569 views
- 6 citations
Original Research
Published on 21 Apr 2020
Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
in Surgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.00530
- 7,797 views
- 25 citations
Original Research
Published on 19 Mar 2021
CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer
in Cancer Imaging and Image-directed Interventions
Frontiers in Oncology
doi 10.3389/fonc.2021.644933
- 6,519 views
- 22 citations
Original Research
Published on 24 Jul 2019
Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2019.00667
- 9,482 views
- 16 citations
Original Research
Published on 29 Apr 2022
Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.890922
- 5,478 views
- 19 citations